Roivant Sciences Ltd.

ROIV ·Healthcare, Drug Manufacturers - General
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Oct 22, 2026 FORM 4
8-K Oct 21, 2026 8-K
4 Oct 20, 2026 FORM 4
4 Oct 20, 2026 FORM 4
144 Oct 20, 2026
SCHEDULE 13D/A Oct 5, 2026
4 Oct 5, 2026 FORM 4
4 Oct 5, 2026 FORM 4
4 Oct 2, 2026 FORM 4
4 Oct 2, 2026 FORM 4
4 Oct 2, 2026 FORM 4
4 Oct 2, 2026 FORM 4
144 Sep 30, 2026
4 Sep 22, 2026 FORM 4
4 Sep 22, 2026 FORM 4
4 Sep 18, 2026 FORM 4
4 Sep 18, 2026 FORM 4
4 Sep 18, 2026 FORM 4
4 Sep 18, 2026 FORM 4
4 Sep 18, 2026 FORM 4
4 Sep 18, 2026 FORM 4
8-K Sep 18, 2026 8-K
4 Sep 17, 2026 FORM 4
4 Sep 17, 2026 FORM 4
144 Sep 15, 2026
← Newer Page 1 of 40 · 988 filings Older →